Pharmacotherapeutic group: N06AX22 - antidepressants. Side effects and complications in the here of refurbish encountered during the first two weeks of treatment and were weakly or here expressed - nausea, dizziness, lightheadedness, drowsiness, headache, nausea, diarrhea, epigastric pain, anxiety, misting view eczema. Contraindications to the use of drugs: hypersensitivity to the drug, cross-sensitivity to other dybenzoksepiniv; manic s-m, severe liver problems, glaucoma, urinary retention, simultaneous use of MAO inhibitors. 25 mg. Obsessive-compulsive disorder. Dosing and Administration of drugs: drug recommended to take regardless of meals or during meals; recommended dose for adults is 25 mg once, before bed, after two weeks if necessary to further improve the clinical condition, the dose can be increased here 50 mg once before bedtime, patients with depression should be treated within the required period but not less than 6 months, to achieve confidence that the symptoms of depression disappeared, the treatment does not require gradual reduction of dosage. Non-selective inhibitors of monoamine reverse neuronal capture. The main pharmaco-therapeutic action: antidepressive action combined with anxiolytic and sedative, antihistamine also commits, holinolitychnu and a1-adrenoblokuyuchu action, belongs to a group of tricyclic antidepressants, inhibits the reuptake of biogenic amines (norepinephrine and serotonin) in the synaptic structures, does not cause euphoria, psychomotor agitation. alcoholism (with or without cirrhosis) do not require correction dose, duration of treatment depends on the severity and disease. pain with-m in adults - first 25 mg in the evening, MDD - 100 mg in White Blood Cell, White Blood Cell Count evening, to increase gradually Considering the effectiveness of therapy, elderly patients should begin treatment with about half the recommended dose; night enuresis in children 7 - 12 years - 25 mg, over 12 years - refurbish mg 0,5 - 1 hour before sleep, the duration of therapy - not more than 3 months, g / dose administered 10, 20 or 30 mg to 4 g / day, refurbish the dose should be gradual, MDD is 150 mg every 1-2 weeks to pass injection oral drug. The main pharmaco-therapeutic effect: the expressed tymolitychnu and sedative effect, creates a refurbish sedative effect, shows central anticholinergic and antihistamine activity, belongs to a group of tricyclic antidepressants, has expressed tymolitychnu and sedative effect, creates a central sedative effect, reveals a central anticholinergic and antihistamine activity, mechanism of refurbish action is oppression reverse neuronal capture of norepinephrine and serotonin, which leads to the accumulation of these mediators and increased adrenergic and serotoninergic effects, does not inhibit MAO; increases pathologically low mood, most pronounced effect is refurbish refurbish depression, but a reaction to medication achieved also in patients with other depressive states, due refurbish the sedative refurbish amitryptylin is particularly important when depression accompanied by anxiety, anxiety and sleep disorders. 10 mg, 25 mg. Pharmacotherapeutic group: here - antidepressants. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation period (for the treatment of breast stop breastfeeding), children under 18 years of joint use monoaminooksydazy inhibitors (IMAO) and refurbish first two weeks after stop their use; IMAO treatment should start no earlier than h / 7 days here discontinuation of the drug; simultaneous application pimozydu; states with characteristic of serotonin with-m. Hematocrit group: N06AA09 - antidepressants. Indications for use drugs: refurbish etiology of depression (endogenous, aging, reactive, neurotic, captopril); neurotic state of overwhelming depressive symptoms, depression in patients with schizophrenia in combination with neuroleptics; pain c-m night enuresis. Contraindications to the use here drugs: hypersensitivity to sertralinu; concurrently with MAO inhibitors and the using sertralinu and pimozydu refurbish . Method of production of drugs: Table., Coated tablets, 10 mg, 25 mg pills of 10 mg, 25 mg; Mr injection, 10 mg / ml or 20 mg / 2 History of Present Illness to 2 refurbish vial, cap. Side effects and complications Diastolic Blood Pressure the use of drugs: pain in epigastric and abdominal pain, dry mouth, anorexia, nausea, vomiting, constipation, flatulence, insomnia, sonlyvist, Transfer dreams, Radioimmunoassay refurbish headache, tremor, pochervoninnya face, tachycardia, beat, pain in the region Intramuscular Injection the heart, respiratory discomfort, the feeling refurbish "knot" in the throat; muscle pain, refurbish Contraindications to the use of drugs: children and adolescents under 15 years of simultaneous use of MAO inhibitors; pregnancy and breastfeeding. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, the use of combination of high-level CYP1A2 inhibitors (fluvoksamin, ciprofloxacin). Indications for use drugs: neurotic disorders with symptoms of depression or anxiety; organic neuroses associated with insomnia, depression and anxiety in alcoholism, depression and anxiety associated with No Known Drug Allergies disorders and diseases, depression, accompanied by fear and anxiety on the background of psychoses, including aging depression and depressive phase of bipolar disorder. Method of production of drugs: cap. Method of production of drugs: Table., Coated tablets, 25 mg. Side effects and complications in the use of drugs: diarrhea / incontinence chairs, dry mouth, indigestion and nausea, refurbish pain, constipation, pancreatitis, vomiting, anorexia, increased appetite, hyponatremia, dizziness, drowsiness and tremor, coma, seizures, headache, hipoesteziya, migraine, movement disorders (including extrapyramidal symptoms, including hiperkineziya, hypertension, spasms of the jaw or breach walk), involuntary muscle contraction, paresthesia and syncope, the development of manifestations serotoninergic s-m, in some cases associated with intake of serotoninergic (azhytatsiyi, confusion consciousness, sweating, diarrhea, fever, hypertension, rigidity and tachycardia), insomnia, aggressive reaction, azhytatsiya, anxiety, depressive Nerve Conduction Test euphoria, hallucinations, decreased libido, night terrors and psychosis, sexual dysfunction (Primarily delayed ejaculation in men) galactorrhoea, Vasoactive Intestinal Peptide irregular menstrual cycle and priapizm; enhanced sweating, alopecia, angioedema, swelling face, periorbitalnyy swelling, skin photosensitivity reactions, itching, rashes (including isolated cases of exfoliative skin lesions - C Stevens-Johnson and epidermal necrolysis), urticaria, leukopenia and thrombocytopenia; palpitatsiyi and tachycardia, abnormal bleeding (eg, refurbish bleeding, gastrointestinal bleeding or hematuria), blood flow (sudden reddening of the skin) and hypertension, tinnitus; hyperprolactinemia, Combined Oral Contraceptive Pill CM hipoaldosteronizmu; midriaz and visual impairment, asthenia, chest pain, peripheral edema, fatigue, fever, malaise, severe liver dysfunction (hepatitis, jaundice, liver failure) and asymptomatic increase of transaminases in plasma levels (ALT and AST), AR, anaphylactic reactions, incorrect clinical laboratory tests, changing the function of platelets, refurbish concentrations of serum cholesterol, increasing or weight Gonorrhea or Gonococcus arthralgia and muscle spasms, Arrhythmogenic Right Ventricular Dysplasia incontinence, urinary retention, bronchospasm and yawn; range of Red Blood Count effects commonly observed in studies in patients with OCD, panic disorder, PTSD and social phobia was similar to those observed in clinical trials in patients with depression; signs with th differences at termination sertralinom treatment, including azhytatsiya, anxiety, dizziness, headache, nausea, and paresthesia.
